is bydureon a glp-1 AstraZeneca's gets facelift, but can it stand out in a market that's only getting tougher? GLP-1 receptor agonists are increasingly

If you are ready to explore a supervised, sustainable path, you need a provider who supports this patient-centered approach

A database entry can support identity review, a review article can describe biochemical context, and an analytical paper can illustrate testing methodology

It was identified through an extensive medicinal chemistry programme focused on compounds lacking the central Ala-Trp dipeptide of GHRP-1, ultimately yielding a compound with a distinct and highly specific pharmacological profile

Some might need shots more often, while others can go longer between them

Cardiomyocyte mitochondria as targets of humoral factors released by remote ischemic preconditioning

doi: 10.2337/dc15-1068 26 DombrowskiSKostevKJacobL